Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 4, 2007

AstraZeneca Acquires Biologics Manufacturing Facility in Canada

  • AstraZeneca acquired a Montreal-based biologics manufacturing facility from DSM Biologics. The facility, occupying 66,000 sq. ft., will be used to manufacture antibody drug candidates for clinical trials and will serve the whole of the AstraZeneca group.

    Work to recommission the facility is expected to begin immediately, and the company plans to commence full scale production in 2009.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »